[HTML][HTML] Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis
D Kögel, AG Letai - Apoptosis, 2014 - Springer
Glioblastoma (GBM) is the most aggressive form of primary brain tumour, with dismal patient
outcome. Treatment failure is associated with intrinsic or acquired apoptosis resistance and …
outcome. Treatment failure is associated with intrinsic or acquired apoptosis resistance and …
Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis
ÁC Murphy, B Weyhenmeyer… - Apoptosis: an …, 2014 - pubmed.ncbi.nlm.nih.gov
Glioblastoma (GBM) is the most aggressive form of primary brain tumour, with dismal patient
outcome. Treatment failure is associated with intrinsic or acquired apoptosis resistance and …
outcome. Treatment failure is associated with intrinsic or acquired apoptosis resistance and …
Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis
ÁC Murphy, B Weyhenmeyer, J Noonan, SM Kilbride… - Apoptosis, 2013 - dash.harvard.edu
Glioblastoma (GBM) is the most aggressive form of primary brain tumour, with dismal patient
outcome. Treatment failure is associated with intrinsic or acquired apoptosis resistance and …
outcome. Treatment failure is associated with intrinsic or acquired apoptosis resistance and …
Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis
ÁC Murphy, B Weyhenmeyer, J Noonan… - Apoptosis: An …, 2014 - search.proquest.com
Glioblastoma (GBM) is the most aggressive form of primary brain tumour, with dismal patient
outcome. Treatment failure is associated with intrinsic or acquired apoptosis resistance and …
outcome. Treatment failure is associated with intrinsic or acquired apoptosis resistance and …
Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis.
ÁC Murphy, B Weyhenmeyer, J Noonan, SM Kilbride… - 2014 - repository.rcsi.com
Glioblastoma (GBM) is the most aggressive form of primary brain tumour, with dismal patient
outcome. Treatment failure is associated with intrinsic or acquired apoptosis resistance and …
outcome. Treatment failure is associated with intrinsic or acquired apoptosis resistance and …
Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis.
ÁC Murphy, B Weyhenmeyer, J Noonan… - … on Programmed Cell …, 2014 - europepmc.org
Glioblastoma (GBM) is the most aggressive form of primary brain tumour, with dismal patient
outcome. Treatment failure is associated with intrinsic or acquired apoptosis resistance and …
outcome. Treatment failure is associated with intrinsic or acquired apoptosis resistance and …
Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis
AC Murphy, B Weyhenmeyer, J Noonan, SM Kilbride… - 2014 - scholarbank.nus.edu.sg
Glioblastoma (GBM) is the most aggressive form of primary brain tumour, with dismal patient
outcome. Treatment failure is associated with intrinsic or acquired apoptosis resistance and …
outcome. Treatment failure is associated with intrinsic or acquired apoptosis resistance and …
[PDF][PDF] Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis
AC Murphy, B Weyhenmeyer, J Noonan, SM Kilbride… - Apoptosis, 2014 - core.ac.uk
Glioblastoma (GBM) is the most aggressive form of primary brain tumour, with dismal patient
outcome. Treatment failure is associated with intrinsic or acquired apoptosis resistance and …
outcome. Treatment failure is associated with intrinsic or acquired apoptosis resistance and …
[HTML][HTML] Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis
ÁC Murphy, B Weyhenmeyer, J Noonan, SM Kilbride… - Apoptosis, 2014 - ncbi.nlm.nih.gov
Glioblastoma (GBM) is the most aggressive form of primary brain tumour, with dismal patient
outcome. Treatment failure is associated with intrinsic or acquired apoptosis resistance and …
outcome. Treatment failure is associated with intrinsic or acquired apoptosis resistance and …
Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis
ÁC Murphy, B Weyhenmeyer, J Noonan, SM Kilbride… - Apoptosis, 2014 - infona.pl
Glioblastoma (GBM) is the most aggressive form of primary brain tumour, with dismal patient
outcome. Treatment failure is associated with intrinsic or acquired apoptosis resistance and …
outcome. Treatment failure is associated with intrinsic or acquired apoptosis resistance and …